High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting.

High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting.

Lysyl oxidase (LOX) has been shown to both promote and suppress tumor progression, but its role in prostate cancer is largely unknown. LOX immunoreactivity was scored in prostate tumor epithelium, tumor stroma and in the tumor-adjacent non-malignant prostate epithelium and stroma. LOX scores in tumo...

Full description

Bibliographic Details
Main Authors: Maria Nilsson, Christina Hägglöf, Peter Hammarsten, Elin Thysell, Pär Stattin, Lars Egevad, Torvald Granfors, Emma Jernberg, Pernilla Wikstrom, Sofia Halin Bergström, Anders Bergh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4621025?pdf=render

Internet

http://europepmc.org/articles/PMC4621025?pdf=render

Similar Items